Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Profiling of Serum Oxylipins During the Earliest Stages of Rheumatoid Arthritis

Arthritis & Rheumatology(2020)10.1002/art.41537Source: DataRank Database

Profiling of Serum Oxylipins During the Earliest Stages of Rheumatoid Arthritis is a research paper published in Arthritis & Rheumatology (2020). On theSindex it has a DataRank of 0. It has been cited 22 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access22 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.09)OA: greenTopics (23)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Roxana Coras ORCID,Mercedes Alpéri ORCID,Patricia López ORCID,Catalina Ulloa,Francisco Javier Ballina‐García

Live enrichment

PubMed:33001576 PMC:PMC7914204 OpenAlex:https://openalex.org/W3089500461

National Institutes of Health

Grant: P30DK063491

National Institutes of Health

Grant: R01AR073324

Instituto de Salud Carlos III

Grant: CD19/00120

Instituto de Salud Carlos III

Grant: PI16/00113

NIAMS NIH HHS

Grant: T32 AR064194

FWCI

1.09

Citation Percentile

0.7%

Citation Trend

2020

2022

2023

2024

2025

2026

greenLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7914204

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/art.41537

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/art.41537

publisherhttps://acrjournals.onlinelibrary.wiley.com/doi/pdf/10.1002/art.41537

Fields of Study

Eicosanoids and Hypertension PharmacologyFatty Acid Research and HealthPharmacogenetics and Drug Metabolism

MeSH Terms

AdultAgedArthritis, RheumatoidFemaleHumansMaleMiddle AgedDiscriminant AnalysisLeast-Squares AnalysisCase-Control StudiesDisease ProgressionAntirheumatic AgentsOxylipins

Keywords

Rheumatoid arthritisInternal medicineOxylipinChemistryImmunologyMedicineBiochemistry

Sustainable Development Goals

SDG 0: Reduced inequalities

Additional file 1 of Lipoxygenase-derived oxylipins are enriched in anti-citrullinated protein antibody (ACPA)-positive individuals at risk for developing rheumatoid arthritis

10.6084/m9.figshare.25231175.v1figshare

Additional file 1 of Lipoxygenase-derived oxylipins are enriched in anti-citrullinated protein antibody (ACPA)-positive individuals at risk for developing rheumatoid arthritis

10.6084/m9.figshare.25231175figshare